Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation ; volume:18 ; number:1 ; day:16 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
Infectious agents and cancer ; 18, Heft 1 (16.10.2023), 1-11, 12.2023
- Creator
-
Parham, Groesbeck P.
Egemen, Didem
Befano, Brian
Mwanahamuntu, Mulindi H.
Rodriguez, Ana Cecilia
Antani, Sameer
Chisele, Samson
Munalula, Mukatimui Kalima
Kaunga, Friday
Musonda, Francis
Malyangu, Evans
Shibemba, Aaron Lunda
Sanjose, Silvia de
Schiffman, Mark
Sahasrabuddhe, Vikrant V.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13027-023-00536-5
- URN
-
urn:nbn:de:101:1-2024020613115512756165
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Parham, Groesbeck P.
- Egemen, Didem
- Befano, Brian
- Mwanahamuntu, Mulindi H.
- Rodriguez, Ana Cecilia
- Antani, Sameer
- Chisele, Samson
- Munalula, Mukatimui Kalima
- Kaunga, Friday
- Musonda, Francis
- Malyangu, Evans
- Shibemba, Aaron Lunda
- Sanjose, Silvia de
- Schiffman, Mark
- Sahasrabuddhe, Vikrant V.
- SpringerLink (Online service)
Other Objects (12)
An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
Prevalence, genotyping and phylogenetic analysis of HPV infecting Palestinian women
The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias
Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
Analytical and clinical evaluation of the HPV DNA Array E1-based genotyping assay
Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay
An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia
AI-Based Information Systems
An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
Prevalence, genotyping and phylogenetic analysis of HPV infecting Palestinian women
The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias
Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
Analytical and clinical evaluation of the HPV DNA Array E1-based genotyping assay
Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay
An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia
AI-Based Information Systems
An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
Prevalence, genotyping and phylogenetic analysis of HPV infecting Palestinian women
The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias
Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
Analytical and clinical evaluation of the HPV DNA Array E1-based genotyping assay
Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay
An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia